1.8400
-0.1500
(-7.54%)
At close: April 10 at 4:00:02 PM EDT
1.7700
-0.07
(-3.80%)
Pre-Market: 4:12:10 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-55,032
-55,032
-47,430
-50,829
-15,304
Investing Cash Flow
-120,463
-120,463
-25,975
-6,299
-1,724
Financing Cash Flow
162,226
162,226
24,391
-1,264
152,754
End Cash Position
40,493
40,493
53,762
102,776
161,168
Income Tax Paid Supplemental Data
--
--
83
--
--
Capital Expenditure
-642
-642
-3,258
-6,299
-1,724
Issuance of Capital Stock
166,507
166,507
--
--
154,612
Repayment of Debt
-149
-149
--
--
--
Repurchase of Capital Stock
-4,183
-4,183
-12
-5
--
Free Cash Flow
-55,674
-55,674
-50,688
-57,128
-17,028
12/31/2021 - 7/19/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABVC ABVC BioPharma, Inc.
1.0500
+7.14%
BDRX Biodexa Pharmaceuticals Plc
1.5700
+3.97%
ZVSA ZyVersa Therapeutics, Inc.
0.7713
-25.12%
ENTO Entero Therapeutics, Inc.
0.4030
-7.89%
ELAB PMGC Holdings Inc.
3.2100
-19.55%
OSRH OSR Holdings, Inc.
1.4700
-3.92%
CDT Conduit Pharmaceuticals Inc.
1.0700
+72.58%
LXEO Lexeo Therapeutics, Inc.
2.1700
-8.05%
HEPA Hepion Pharmaceuticals, Inc.
0.4311
-11.62%
ONCO Onconetix, Inc.
0.0580
-8.81%